Андрология и генитальная хирургия. 2015; 16: 46-50
Сравнительный анализ гистологических данных до и после радикальной простатэктомии у больных с низким дооперационным онкологическим риском
https://doi.org/10.17650/2070-9781-2015-16-4-46-50Аннотация
Список литературы
1. Quinn M., Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002;90(2):162–73.
2. Ries L.A.G., Kosary C.L., Hankey B.F. et al. SEER Cancer Statistics Review 1973–1995. Bethesda, MD: National Cancer Institute, 1998.
3. Чиссов В.И., Русаков И.Г. Заболеваемость раком предстательной железы в Российской Федерации. Экспериментальная и клиническая урология 2011; (2–3):6–7. [Chissov V.I., Rusakov I.G. Prostate cancer rate in the Russian Federation. Eksperimental,naya i klinicheskaya urologiya = Experimental and Clinical Urology 2011;(2–3):6–7. (In Russ.)].
4. Parkin D.M., Pisani P., Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54(4):594–606.
5. Catalona W.J., Richie J.P., Ahmann F.R. et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of multicenter clinical trial of 6630 men. J Urol 1994;151(5): 1283–90.
6. Billis A., Guimaraes M.S., Freitas L.L. et al. The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol 2008;180 (2):548–52.
7. Bill-Axelson A., Holmberg L., Filen F. et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group – 4 randomized trial. J Natl Cancer Inst 2008;100(16):1144–54.
8. Tewari A., Johnson C.C., Divine G. et al. Long-term survival probability in men with clinically localized prostate cancer: a casecontrol, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004;171(4):1513–9.
9. Djavan B., Kadesky K., Klopukh B. et al. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol 1998;33(3):261–70.
10. Gleason D. Classification of prostate carcinomas. Cancer Chemother Rep 1966;50(3):125–28.
11. Baillar J., Mellinger G., Gleason D. Survival rates of patients with prostatic cancer, tumor stage and differentiation. Cancer Chemother Rep 1966;50:129–36.
12. Gleason D.F., Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111(1):58–64.
13. Gleason D.F. Histological grading and clinical staging of prostatic carcinoma. In: Urologic pathology: The prostate. Philadelphia, 1977. Pp. 171–97.
Andrology and Genital Surgery. 2015; 16: 46-50
Сomparative analysis of the histologic data before and after radical prostatectomy patients with low pre-operative cancer risk
https://doi.org/10.17650/2070-9781-2015-16-4-46-50Abstract
References
1. Quinn M., Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002;90(2):162–73.
2. Ries L.A.G., Kosary C.L., Hankey B.F. et al. SEER Cancer Statistics Review 1973–1995. Bethesda, MD: National Cancer Institute, 1998.
3. Chissov V.I., Rusakov I.G. Zabolevaemost' rakom predstatel'noi zhelezy v Rossiiskoi Federatsii. Eksperimental'naya i klinicheskaya urologiya 2011; (2–3):6–7. [Chissov V.I., Rusakov I.G. Prostate cancer rate in the Russian Federation. Eksperimental,naya i klinicheskaya urologiya = Experimental and Clinical Urology 2011;(2–3):6–7. (In Russ.)].
4. Parkin D.M., Pisani P., Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54(4):594–606.
5. Catalona W.J., Richie J.P., Ahmann F.R. et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of multicenter clinical trial of 6630 men. J Urol 1994;151(5): 1283–90.
6. Billis A., Guimaraes M.S., Freitas L.L. et al. The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol 2008;180 (2):548–52.
7. Bill-Axelson A., Holmberg L., Filen F. et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group – 4 randomized trial. J Natl Cancer Inst 2008;100(16):1144–54.
8. Tewari A., Johnson C.C., Divine G. et al. Long-term survival probability in men with clinically localized prostate cancer: a casecontrol, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004;171(4):1513–9.
9. Djavan B., Kadesky K., Klopukh B. et al. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol 1998;33(3):261–70.
10. Gleason D. Classification of prostate carcinomas. Cancer Chemother Rep 1966;50(3):125–28.
11. Baillar J., Mellinger G., Gleason D. Survival rates of patients with prostatic cancer, tumor stage and differentiation. Cancer Chemother Rep 1966;50:129–36.
12. Gleason D.F., Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111(1):58–64.
13. Gleason D.F. Histological grading and clinical staging of prostatic carcinoma. In: Urologic pathology: The prostate. Philadelphia, 1977. Pp. 171–97.
